Medications for Alzheimer's disease are designed to alleviate symptoms and slow its progression. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine are frequently prescribed to enhance nerve cell communication and preserve cognitive function. Another class of drugs, memantine, regulates glutamate activity, crucial for memory and learning processes. While these medications don't cure Alzheimer's, they can help manage symptoms such as memory loss, confusion, and behavioral changes, potentially improving patients' quality of life. Due to varying responses and possible side effects, careful monitoring and adjustments are necessary. Ongoing research aims to develop new treatments that could alter the disease's course or provide more effective relief for individuals with Alzheimer's and related dementias.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China